The Athletics Integrity Unit (AIU) conducted 13,276 doping-control sample collections in 2025, compared with 12,982 in 2024, according to its last year’s annual report. The figures show a modest increase in overall testing activity, with more athletes covered and a broader geographical reach.

The AIU also conducted 17,804 analyses during 2025, compared with 18,153 in 2024. The number of athletes tested increased from 3,744 to 3,930, while the number of competitions at which testing was conducted rose from 522 to 525.

The 2025 programme covered athletes representing 143 nationalities, compared with 139 in 2024.

KEY AIU TESTING NUMBERS: 2024 VS 2025

Testing statistics 2024 2025
Doping-control samples 12,982 13,276
Analyses performed 18,153 17,804
Athletes tested 3,744 3,930
Registered Testing Pool athletes 838 767
Competitions covered 522 525
Nationalities represented 139 143

The number of doping-control samples increased by approximately 2.3%, while the number of athletes covered increased by nearly 5%. However, the number of athletes in the AIU’s Registered Testing Pool (RTP) declined from 838 to 767.

Africa remains the biggest testing region, but its share declines

One of the most interesting findings in the AIU report is the continent-wise distribution of testing.

Africa continued to account for the largest share of the AIU’s testing programme in 2025, but its proportion fell considerably compared with 2024.

In 2024, Africa accounted for 48.14% of the testing distribution. In 2025, this figure declined to 42%.

Based on the total number of samples collected and the continent-wise percentages published by the AIU, this represents approximately 6,250 samples associated with Africa in 2024 and around 5,576 in 2025.

This is an estimated decline of approximately 11%, despite a slight increase in the AIU’s overall global testing volume.

Africa nevertheless remained well ahead of other continents.

The 2025 geographical distribution was:

  • Africa: 42%
  • Europe: 30%
  • North America: 15%
  • Asia: 8%
  • South America: 3%
  • Oceania: 2%

Europe’s share increased from 26.34% in 2024 to 30% in 2025, while North America’s share rose from 12.13% to 15%.

Asia’s share, meanwhile, declined from 9.59% to 8%.

The AIU’s figures underline the continuing importance of Africa in international athletics anti-doping operations, particularly given the continent’s strong presence in middle- and long-distance running.

AIU shifts greater attention to sprints and power events

Another significant development in 2025 was the AIU’s decision to rebalance its testing programme towards power and strength disciplines.

For several years, endurance events received a greater share of attention, partly because anti-doping science has historically been more effective at detecting certain forms of doping in endurance disciplines and because road-race testing received additional funding.

However, the AIU began increasing its focus on sprints, throws, and other power-based events in 2025.

The discipline-wise distribution shows the change:

Discipline 2024 2025
Long distance 63% 53%
Sprints 14% 18%
Middle distance 8% 10%
Throws 7% 9%
Jumps 6% 7%
Combined events 2% 2%
Trail/Mountain running \- 1%

Long-distance events continued to receive the largest share, although their proportion declined by 10 percentage points.

Sprints recorded the biggest increase among the established track and field disciplines, rising from 14% to 18%. Throws increased from 7% to 9%, while middle-distance events rose from 8% to 10%.

The AIU also selected more sprint and throws athletes for its Registered Testing Pool, increased detection testing for steroids and Human Growth Hormones, and worked to strengthen testing capacity in countries such as Jamaica and the United States.

This change is important as it indicates that the AIU is looking beyond traditional endurance-event testing and giving greater attention to doping risks across different disciplines.

Paris 2024 Vs Tokyo 2025: How did pre-championship testing compare?

The two annual reports also provide an opportunity to compare anti-doping testing ahead of two major international competitions: the Paris 2024 Olympic Games and the Tokyo 2025 World Athletics Championships.

Ahead of Paris 2024:

  • 10,112 doping controls were conducted on 1,876 athletes.
  • The programme included 7,080 out-of-competition (OOC) tests.
  • Athletes received an average of 5.4 tests each.
  • The AIU conducted 39% of the OOC tests, while National Anti-Doping Organisations (NADOs) conducted 61%.
  • 97% of athletics medallists were included in AIU testing pools.
  • Every athletics medallist received at least one out-of-competition test before the Games.

Ahead of Tokyo 2025:

  • 9,640 tests were conducted on 2,006 athletes during the 10 months leading up to the World Championships.
  • These included 6,193 no-notice out-of-competition tests.
  • Approximately 4.8 tests were conducted per athlete, calculated from the reported totals.
  • 53% of athletes competing in Tokyo received three or more out-of-competition tests.
  • Among the top eight finishers, the figure was considerably higher, with 95% receiving three or more such tests.

At the Tokyo World Athletics Championships itself, the AIU, working with the Japanese Anti-Doping Agency, conducted 1,014 in-competition and out-of-competition tests, involving 1,214 urine and blood samples.

India moved to category A: More testing expected in the coming season

For Indian athletics, one of the most important developments came after the period covered by the 2025 report.

On April 20, 2026, the Athletics Integrity Unit announced that the Athletics Federation of India (AFI) had been reclassified from Category B to Category A under Rule 15 of the World Athletics Anti-Doping Rules.

Category A represents the highest doping-risk category under the framework and comes with more stringent anti-doping requirements.

The AIU decision was linked to India’s consistently high number of Anti-Doping Rule Violations (ADRVs) in athletics.

According to the AIU:

  • 2022: 48 ADRVs – 2nd highest globally
  • 2023: 63 ADRVs – 2nd highest globally
  • 2024: 71 ADRVs – highest globally
  • 2025: 30 ADRVs recorded at the time of the April 2026 announcement – highest globally

The AIU also clarified that the 2025 figure was subject to a substantial reporting delay, meaning the final number could change.

What does category A mean for Indian athletes?

The reclassification brings stricter testing requirements, particularly for athletes representing India at the World Athletics Championships and Olympic Games.

Under the Category A requirements in Rule 15, athletes selected for these national teams must undergo at least three unannounced out-of-competition tests within the 10 months before the testing deadline set for the relevant event.

These tests must:

  • Be conducted without prior notice.
  • Have at least 21 full days between each test.
  • Include the first test no later than 24 weeks before the start of the event.

Category A federations must also maintain an effective annual testing programme that includes in-competition testing, unannounced out-of-competition testing, and pre-competition blood testing. Samples must undergo full-menu analysis at WADA-accredited or WADA-approved laboratories.

Importantly, athletes training or residing outside India are not exempt. The federation must ensure that they are tested abroad as well.

These requirements mean that Indian athletes targeting major international championships can expect closer monitoring, more frequent unannounced testing, and stricter checks well before competition.

The change is particularly significant for the upcoming 2027 World Athletics Championships cycle and future Olympic preparations. Athletes will need to meet the required testing conditions to remain eligible for selection and participation.

More than just testing: AIU’S case management in 2025

The AIU’s 2025 report also highlighted its continued action against doping violations involving international-level athletes.

More than 70 doping cases were decided during the year, with successful prosecutions involving athletes including marathon world record-holder Ruth Chepngetich and American sprinter Erriyon Knighton.